Evidence map›Paper›PMID 37431773›Full record

ReviewBiochemical Society transactions2023

Structural insights into NMDA receptor pharmacology.

Changping Zhou, Nami Tajima

Open access · hybridAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Phytochemicals with potential NMDAR-inhibitory activities: a review of neuroprotective mechanisms against excitotoxicity.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Hydrogen Sulfide (HInternational journal of molecular sciences · 2025
    Review
  15. Article
  16. Future Perspectives of NMDAR in CNS Disorders.Molecules (Basel, Switzerland) · 2025
    Review
  17. Design of (Journal of medicinal chemistry · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Changping ZhouDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, U.S.A.
Nami TajimaDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, U.S.A.ORCID 0000-0001-7773-7391
Case Western Reserve University · US

Funding

Structure and Function of native kainate-type ionotropic glutamate receptor complexesR35GM147266 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI NAMI TAJIMA · 2022 to 2026
$2.1M
NIGMS NIH HHS R35 GM147266
6 · The paper itself

Abstract

N-methyl-d-aspartate receptors (NMDARs) comprise a subfamily of ionotropic glutamate receptors that form heterotetrameric ligand-gated ion channels and play fundamental roles in neuronal processes such as synaptic signaling and plasticity. Given their critical roles in brain function and their therapeutic importance, enormous research efforts have been devoted to elucidating the structure and function of these receptors and developing novel therapeutics. Recent studies have resolved the structures of NMDARs in multiple functional states, and have revealed the detailed gating mechanism, which was found to be distinct from that of other ionotropic glutamate receptors. This review provides a brief overview of the recent progress in understanding the structures of NMDARs and the mechanisms underlying their function, focusing on subtype-specific, ligand-induced conformational dynamics.

Indexed as

Receptors, Ionotropic GlutamateReceptors, N-Methyl-D-AspartateCell CommunicationSignal TransductionReceptors, Ionotropic GlutamateReceptors, N-Methyl-D-Aspartateglutamate receptorneuropharmacologystructure

Identifiers

PMID37431773
PMCPMC10586783
OpenAlexW4383873178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.